Cargando…
Prescreening for COVID-19 in patients receiving cancer treatment using a patient-reported outcome platform
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307523/ https://www.ncbi.nlm.nih.gov/pubmed/32571785 http://dx.doi.org/10.1136/esmoopen-2020-000817 |
| _version_ | 1783548825174016000 |
|---|---|
| author | Peeters, Marc van Dam, Peter Rasschaert, Marika Anna Vulsteke, Christof De Keersmaecker, Sven Croes, Lieselot Van Brussel, Ilse Ravelingien, Jo Janssens, Annelies Prenen, Hans |
| author_facet | Peeters, Marc van Dam, Peter Rasschaert, Marika Anna Vulsteke, Christof De Keersmaecker, Sven Croes, Lieselot Van Brussel, Ilse Ravelingien, Jo Janssens, Annelies Prenen, Hans |
| author_sort | Peeters, Marc |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7307523 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | BMJ Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73075232020-06-23 Prescreening for COVID-19 in patients receiving cancer treatment using a patient-reported outcome platform Peeters, Marc van Dam, Peter Rasschaert, Marika Anna Vulsteke, Christof De Keersmaecker, Sven Croes, Lieselot Van Brussel, Ilse Ravelingien, Jo Janssens, Annelies Prenen, Hans ESMO Open Correspondence BMJ Publishing Group 2020-06-21 /pmc/articles/PMC7307523/ /pubmed/32571785 http://dx.doi.org/10.1136/esmoopen-2020-000817 Text en © Author (s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ on behalf of the European Society for Medical Oncology. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, any changes made are indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
| spellingShingle | Correspondence Peeters, Marc van Dam, Peter Rasschaert, Marika Anna Vulsteke, Christof De Keersmaecker, Sven Croes, Lieselot Van Brussel, Ilse Ravelingien, Jo Janssens, Annelies Prenen, Hans Prescreening for COVID-19 in patients receiving cancer treatment using a patient-reported outcome platform |
| title | Prescreening for COVID-19 in patients receiving cancer treatment using a patient-reported outcome platform |
| title_full | Prescreening for COVID-19 in patients receiving cancer treatment using a patient-reported outcome platform |
| title_fullStr | Prescreening for COVID-19 in patients receiving cancer treatment using a patient-reported outcome platform |
| title_full_unstemmed | Prescreening for COVID-19 in patients receiving cancer treatment using a patient-reported outcome platform |
| title_short | Prescreening for COVID-19 in patients receiving cancer treatment using a patient-reported outcome platform |
| title_sort | prescreening for covid-19 in patients receiving cancer treatment using a patient-reported outcome platform |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307523/ https://www.ncbi.nlm.nih.gov/pubmed/32571785 http://dx.doi.org/10.1136/esmoopen-2020-000817 |
| work_keys_str_mv | AT peetersmarc prescreeningforcovid19inpatientsreceivingcancertreatmentusingapatientreportedoutcomeplatform AT vandampeter prescreeningforcovid19inpatientsreceivingcancertreatmentusingapatientreportedoutcomeplatform AT rasschaertmarikaanna prescreeningforcovid19inpatientsreceivingcancertreatmentusingapatientreportedoutcomeplatform AT vulstekechristof prescreeningforcovid19inpatientsreceivingcancertreatmentusingapatientreportedoutcomeplatform AT dekeersmaeckersven prescreeningforcovid19inpatientsreceivingcancertreatmentusingapatientreportedoutcomeplatform AT croeslieselot prescreeningforcovid19inpatientsreceivingcancertreatmentusingapatientreportedoutcomeplatform AT vanbrusselilse prescreeningforcovid19inpatientsreceivingcancertreatmentusingapatientreportedoutcomeplatform AT ravelingienjo prescreeningforcovid19inpatientsreceivingcancertreatmentusingapatientreportedoutcomeplatform AT janssensannelies prescreeningforcovid19inpatientsreceivingcancertreatmentusingapatientreportedoutcomeplatform AT prenenhans prescreeningforcovid19inpatientsreceivingcancertreatmentusingapatientreportedoutcomeplatform |